Publix keeps pace with innovation
Publix routinely makes strategic moves to enhance the customer experience in the pharmacy and health-and-wellness arena that are rooted in the customer service mindset that has made its supermarkets so popular.
Last fall the company introduced a new larger, triangular-shaped pill bottle that is designed to be easier to open. While the pill bottle redesign didn’t go as far as the award-winning program Target introduced a few years back, the move underscored the fact that Publix is a pharmacy innovator.
It is a company that seeks its own unique position in the marketplace while others follow the leader. When Walmart launched a $4 generic program roughly four years ago and others quickly followed suit, Publix charted a different course with a free antibiotic program.
Publix also made sure it kept pace with competitive trends so its pharmacies offer flu shots and various other health screenings throughout the year, and was an early adopter of retail clinics through an affiliation with the The Little Clinic, which was acquired by Kroger in February 2010. Today, the 40 clinics are operated
by Health Solera.
Last year, Publix launched the first phase of a multifaceted diabetes management program that included free metformin for Type 2 diabetes patients in addition to resources to help manage medications, compliance and monitoring.
Keryx to present phase-3 clinical data for Zerenex at conference
NEW YORK — Late-stage clinical trial data for a Keryx Biopharmaceuticals drug to treat kidney disease will be presented at a medical conference in Las Vegas.
Keryx said Monday that phase-3 data for the drug Zerenex (ferric citrate), a drug for abnormally high phosphate levels in patients with end-stage kidney disease on dialysis, will be presented at the upcoming National Kidney Foundation spring clinical meetings in April.
The company announced “positive” results from a phase-3 trial of the drug in November.
Kroger building a patient-care powerhouse
The nation’s largest supermarket chain wants a bigger share of the U.S. pharmacy and wellness market. To get it, Kroger is brandishing a growing arsenal of health and preventive services, and burnishing its image for value and convenience at the prescription counter.
Kroger is the fifth-largest chain pharmacy operator in the United States in number of locations, and filled more than 136 million prescriptions last year, worth approximately $6.9 billion. The chain has added drive-through pharmacies to some 750 of its locations, and opened up and realigned its pharmacies to make them easier for shoppers to access.
“In addition to convenience, our pharmacies strive to provide good value” with a $4 generic pricing program that now includes more than 300 drugs, noted the company. “We also offer 90-day supplies of many of these prescriptions for $10, and we have increased the number of women’s health medications that we offer at discounted prices.”
Kroger also is aggressively growing its menu of pharmacy- and clinic-based health services. Some of its stores now offer a variety of biometric health screenings for cholesterol, diabetes and body fat with rapid blood-test results that can be forwarded to the family physician. Other services include a smoking-cessation program; a 12-week fitness, nutrition and weight-loss program; diabetes education and coaching by registered dietitians, certified diabetes educators and pharmacists with certification in diabetes management; and travel vaccines and adult immunizations. The chain also operates 77 in-store clinics through The Little Clinic, which it purchased in 2010.